Israeli bio-food-tech company Maolac has introduced innovative products that combine traditional components with advanced technology: breastmilk and AI.
These products — Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity — have been developed using artificial intelligence and the company's “Maoreka” algorithm. The global market for immune-boosting foods is projected to reach $46.9 billion by 2030, and Maolac's approach is expected to bring significant changes.
Read more...
These products — Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity — have been developed using artificial intelligence and the company's “Maoreka” algorithm. The global market for immune-boosting foods is projected to reach $46.9 billion by 2030, and Maolac's approach is expected to bring significant changes.
Read more...